VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
MTNB
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
MTNBMatinas BioPharma Holdings, Inc.
$0.62$3M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksMTNBQuarterly Financials

Matinas BioPharma Holdings, Inc. (MTNB) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Matinas BioPharma Holdings, Inc. (MTNB) quarterly income statement — complete revenue, gross profit & net income history

MTNB Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue0000000000001.1M1.06M1.06M1.06M0-33300
Revenue Growth %---------100%-100%-100%-100%-319319.22%---100%-100.53%-100%-
Cost of Goods Sold74K-85K114K124K85K2.38M2.24M3.37M240K3.67M3.29M3.56M3.97M3.87M3.71M4.13M4.98M4.24M4.62M2.48M
COGS % of Revenue------------362.23%363.78%348.73%388.24%--1273137.84%--
Gross Profit-74K85K-114K-124K-85K-2.38M-2.24M-3.37M-240K-3.67M-3.29M-3.56M-2.87M-2.8M-2.64M-3.06M-4.98M-4.24M-4.62M-2.48M
Gross Margin %-------------262.23%-263.78%-248.73%-288.24%-1273237.84%--
Gross Profit Growth %12.94%103.58%94.91%96.32%64.58%35.17%32.05%5.28%91.65%-30.71%-24.62%-16.16%42.27%33.87%42.79%-23.51%-55.17%-22.43%-42.61%27.26%
Operating Expenses1.86M1.69M1.58M1.84M1.86M6.09M2.14M2.47M5.66M2.22M2.84M2.6M2.71M2.68M2.82M2.86M2.74M2.47M2.26M2.31M
OpEx % of Revenue------------247.45%251.74%265.1%269.14%--743055.56%--
Selling, General & Admin1.94M1.6M1.58M1.84M1.86M1.66M2.14M2.47M2.22M2.22M2.84M2.6M2.71M2.68M2.82M2.86M2.74M2.47M2.26M2.31M
SG&A % of Revenue------------247.45%251.74%265.1%269.14%--743055.56%--
Research & Development000085K2.38M2.24M3.37M3.45M3.67M3.29M3.56M3.97M3.87M3.71M4.13M4.98M4.24M4.62M2.48M
R&D % of Revenue------------362.23%363.78%348.73%388.24%--1273137.84%--
Other Operating Expenses-74K85K00-85K1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K
Operating Income-1.94M-1.6M-1.58M-1.84M-1.95M-8.47M-4.38M-5.84M-5.9M-5.89M-6.13M-6.16M-5.59M-5.48M-5.46M-5.92M-7.72M-6.71M-6.88M-4.79M
Operating Margin %-------------509.67%-515.52%-513.83%-557.38%-2016293.39%--
Operating Income Growth %0.51%81.11%64%68.54%67.03%-43.86%28.58%5.2%-5.66%-7.43%-12.3%-3.95%27.66%18.38%20.59%-23.7%-21.55%-3.47%-22.72%16.94%
EBITDA-1.86M-1.18M-1.47M-1.82M-1.93M-8.38M-4.29M-5.75M-5.66M-5.79M-6.03M-6.06M-5.49M-5.38M-5.37M-5.83M-7.65M-6.64M-6.81M-4.72M
EBITDA Margin %-------------500.82%-506.4%-505.17%-548.73%-1994888.29%--
EBITDA Growth %3.37%85.95%65.82%68.26%65.97%-44.72%28.92%5.18%-3.15%-7.54%-12.37%-3.91%28.22%18.97%21.11%-23.52%-21.72%-3.43%-22.91%17%
D&A (Non-Cash Add-back)74K423K111K13K19K91K92K92K240K98K100K98K97K97K92K92K75K71.28K70.86K67.2K
EBIT-1.92M-1.03M-2.15M-5.25M-1.66M-4.04M-4.28M-5.72M-5.82M-5.31M-6.05M-6.06M-5.51M-3.63M-5.46M-5.92M-5.98M-6.7M-6.84M-4.79M
Net Interest Income00000000000000000000
Interest Income00000000000000000000
Interest Expense00000000000000000000
Other Income/Expense15K-312K-573K-3.41M290K-44K106K120K78K573K79K99K73K1.85M9882K1.74M15.23K41.39K-1.42K
Pretax Income-1.92M-1.91M-2.15M-5.25M-1.66M-8.51M-4.28M-5.72M-5.82M-5.31M-6.05M-6.06M-5.51M-3.63M-5.46M-5.92M-5.98M-6.7M-6.84M-4.79M
Pretax Margin %-------------503.01%-341.86%-513.83%-557.2%-2011719.22%--
Income Tax00000-80K00000000000000
Effective Tax Rate %0%0%0%0%0%0.94%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-1.92M-1.91M-2.15M-5.25M-1.66M-8.43M-4.28M-5.72M-5.82M-5.31M-6.05M-6.06M-5.51M-3.63M-5.46M-5.92M-5.98M-6.7M-6.84M-4.79M
Net Margin %-------------503.01%-341.86%-513.83%-557.2%-2011719.22%--
Net Income Growth %-16%77.33%49.71%8.29%71.57%-58.69%29.4%5.63%-5.64%-46.23%-10.86%-2.31%7.78%45.75%20.11%-23.62%-20.61%-5.65%-25.45%14.61%
Net Income (Continuing)-1.92M-1.91M-2.15M-5.25M-1.66M-8.43M-4.28M-5.72M-5.82M-5.31M-6.05M-6.06M-5.51M-3.63M-5.46M-5.92M-5.98M-6.7M-6.84M-4.79M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.30-0.30-0.40-1.03-0.33-1.73-0.85-1.15-1.34-1.22-1.39-1.39-1.25-0.01-1.26-1.36-0.58-1.55-1.59-1.17
EPS Growth %9.09%82.66%52.94%10.43%75.37%-41.8%38.85%17.27%-7.2%--10.32%-2.21%-115.52%99.52%20.75%-16.24%52.46%2.52%-16.06%17.61%
EPS (Basic)-0.30-0.30-0.40-1.03-0.33-1.73-0.85-1.15-1.34-1.22-1.39-1.39-1.25-0.01-1.26-1.36-0.58-1.55-1.59-1.17
Diluted Shares Outstanding6.41M5.47M5.44M5.09M5.09M4.87M5.04M4.99M4.35M4.35M4.35M4.35M4.35M4.34M4.34M4.34M4.33M4.33M4.3M4.1M
Basic Shares Outstanding6.41M5.47M5.44M5.09M5.09M4.87M5.04M4.99M4.35M4.35M4.35M4.35M4.35M4.34M4.34M4.34M4.33M4.33M4.3M4.1M
Dividend Payout Ratio--------------------